Invited Commentary: Assessing Gastric and Gastroesophageal Junction Cancer Patient Prognosis in the Neoadjuvant Therapy Era
J Am Coll Surg
.
2022 Aug 1;235(2):304-305.
doi: 10.1097/XCS.0000000000000216.
Epub 2022 May 6.
Authors
John D Karalis
1
,
Sam C Wang
Affiliation
1
Dallas, TX.
PMID:
35839407
DOI:
10.1097/XCS.0000000000000216
No abstract available
Publication types
Comment
MeSH terms
Esophageal Neoplasms* / therapy
Esophagogastric Junction
Humans
Neoadjuvant Therapy
Neoplasms*
Prognosis
Stomach Neoplasms* / surgery